It was observed that the increased tumor development in IL-10−/− mice resulted from multiple intertwined mechanisms: increased immunosuppression, enhanced inflammation, and possible reduced effector T cell function and tumor trafficking in tumor-bearing hosts. The gene discussed is IL10; the disease is neoplasm.